Healthcare · Biotechnology · NASDAQ
| Market cap | $16.75B |
|---|---|
| Trailing P/E | — |
| FCF yield | 0.3% |
| Revenue growth (YoY) | +98.0% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Ascendis Pharma A/S trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Gary Palmer | House | Buy | $1,001 - $15,000 | Aug 6, 2018 |
| Gary Palmer | House | Buy | $1,001 - $15,000 | Jul 12, 2018 |